-
-
-
-
-
-
-
Livanova (LIVN) PT Raised to $81 at Needham
-
-
-
-
-
-
-
LivaNova names Lucile Blaise global head of sleep apnea unit
-
-
-
-
-
-
-
Livanova (LIVN) PT Raised to $58 at Barclays
-
-
-
-
-
-
-
LivaNova (LIVN) Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Livanova (LIVN)
-
-
-
-
-
-
-
Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval
-
-
-
-
-
-
-
Baird Upgrades Livanova (LIVN) to Outperform
-
413,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

